METHODS	Children 6 to 59 months of age , without a recent episode of wheezing illness or severe asthma , were randomly assigned in a 1:1 ratio to receive either cold-adapted trivalent live attenuated influenza vaccine ( a refrigeration-stable formulation of live attenuated intranasally administered influenza vaccine ) or trivalent inactivated vaccine in a double-blind manner .\